Cargando…

(18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification

BACKGROUND: The aim of this study was to evaluate the effect of a model combining a 18F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT)-based radiomics signature with clinical factors in the preoperative prediction of the International Neuroblastoma Pathology C...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Luo-Dan, Feng, Li-Juan, Zhang, Shu-Xin, Liu, Jun, Ren, Jia-Liang, Liu, Lei, Zhang, Hui, Yang, Jigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816755/
https://www.ncbi.nlm.nih.gov/pubmed/36620179
http://dx.doi.org/10.21037/qims-22-343
_version_ 1784864609385054208
author Qian, Luo-Dan
Feng, Li-Juan
Zhang, Shu-Xin
Liu, Jun
Ren, Jia-Liang
Liu, Lei
Zhang, Hui
Yang, Jigang
author_facet Qian, Luo-Dan
Feng, Li-Juan
Zhang, Shu-Xin
Liu, Jun
Ren, Jia-Liang
Liu, Lei
Zhang, Hui
Yang, Jigang
author_sort Qian, Luo-Dan
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the effect of a model combining a 18F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT)-based radiomics signature with clinical factors in the preoperative prediction of the International Neuroblastoma Pathology Classification (INPC) type of pediatric peripheral neuroblastic tumor (pNT). METHODS: A total of 106 consecutive pediatric pNT patients confirmed by pathology were retrospectively analyzed. Significant features determined by multivariate logistic regression were retained to establish a clinical model (C-model), which included clinical parameters and PET/CT radiographic features. A radiomics model (R-model) was constructed on the basis of PET and CT images. A semiautomatic method was used for segmenting regions of interest. A total of 1,016 radiomics features were extracted. Univariate analysis and the least absolute shrinkage selection operator were then used to select significant features. The C-model was combined with the R-model to establish a combination model (RC-model). The predictive performance was validated by receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA) in both the training cohort and validation cohort. RESULTS: The radiomics signature was constructed using 5 selected radiomics features. The RC-model, which was based on the 5 radiomics features and 3 clinical factors, showed better predictive performance compared with the C-model alone [area under the curve in the validation cohort: 0.908 vs. 0.803; accuracy: 0.903 vs. 0.710; sensitivity: 0.895 vs. 0.789; specificity: 0.917 vs. 0.583; net reclassification improvement (NRI) 0.439, 95% confidence interval (CI): 0.1047–0.773; P=0.01]. The calibration curve showed that the RC-model had goodness of fit, and DCA confirmed its clinical utility. CONCLUSIONS: In this preliminary single-center retrospective study, an R-model based on (18)F-FDG PET/CT was shown to be promising in predicting INPC type in pediatric pNT, allowing for the noninvasive prediction of INPC and assisting in therapeutic strategies.
format Online
Article
Text
id pubmed-9816755
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98167552023-01-07 (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification Qian, Luo-Dan Feng, Li-Juan Zhang, Shu-Xin Liu, Jun Ren, Jia-Liang Liu, Lei Zhang, Hui Yang, Jigang Quant Imaging Med Surg Original Article BACKGROUND: The aim of this study was to evaluate the effect of a model combining a 18F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT)-based radiomics signature with clinical factors in the preoperative prediction of the International Neuroblastoma Pathology Classification (INPC) type of pediatric peripheral neuroblastic tumor (pNT). METHODS: A total of 106 consecutive pediatric pNT patients confirmed by pathology were retrospectively analyzed. Significant features determined by multivariate logistic regression were retained to establish a clinical model (C-model), which included clinical parameters and PET/CT radiographic features. A radiomics model (R-model) was constructed on the basis of PET and CT images. A semiautomatic method was used for segmenting regions of interest. A total of 1,016 radiomics features were extracted. Univariate analysis and the least absolute shrinkage selection operator were then used to select significant features. The C-model was combined with the R-model to establish a combination model (RC-model). The predictive performance was validated by receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA) in both the training cohort and validation cohort. RESULTS: The radiomics signature was constructed using 5 selected radiomics features. The RC-model, which was based on the 5 radiomics features and 3 clinical factors, showed better predictive performance compared with the C-model alone [area under the curve in the validation cohort: 0.908 vs. 0.803; accuracy: 0.903 vs. 0.710; sensitivity: 0.895 vs. 0.789; specificity: 0.917 vs. 0.583; net reclassification improvement (NRI) 0.439, 95% confidence interval (CI): 0.1047–0.773; P=0.01]. The calibration curve showed that the RC-model had goodness of fit, and DCA confirmed its clinical utility. CONCLUSIONS: In this preliminary single-center retrospective study, an R-model based on (18)F-FDG PET/CT was shown to be promising in predicting INPC type in pediatric pNT, allowing for the noninvasive prediction of INPC and assisting in therapeutic strategies. AME Publishing Company 2022-10-10 2023-01-01 /pmc/articles/PMC9816755/ /pubmed/36620179 http://dx.doi.org/10.21037/qims-22-343 Text en 2023 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Qian, Luo-Dan
Feng, Li-Juan
Zhang, Shu-Xin
Liu, Jun
Ren, Jia-Liang
Liu, Lei
Zhang, Hui
Yang, Jigang
(18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title_full (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title_fullStr (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title_full_unstemmed (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title_short (18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
title_sort (18)f-fdg pet/ct imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the international neuroblastoma pathology classification
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816755/
https://www.ncbi.nlm.nih.gov/pubmed/36620179
http://dx.doi.org/10.21037/qims-22-343
work_keys_str_mv AT qianluodan 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT fenglijuan 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT zhangshuxin 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT liujun 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT renjialiang 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT liulei 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT zhanghui 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification
AT yangjigang 18ffdgpetctimagingofpediatricperipheralneuroblastictumoracombinedmodeltopredicttheinternationalneuroblastomapathologyclassification